Effects of acotiamide on patients with esophageal motility disorders

Effects of acotiamide on patients with esophageal motility disorders - Acotiamide and esophageal motility disorders

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000015248

Enrollment

100

Registered

2014-10-01

Start date

2014-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia with esophageal motility disorders

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients older than 20 years old. 2. Patients with functional dyspepsia suffering from abdominal fullness, bloating, early satiation. 3. Patients who also have symptoms suspecting esophageal motility disorders, which is confirmed by High resolution manometry. 4. Patients where written informed consent is obtained.

Exclusion criteria

Exclusion criteria: 1. Patients who are not candidate for acotiamide treatment. 2. Patients who are judged as being inappropriate for this study by their medical doctors.

Design outcomes

Primary

Measure	Time frame
symptoms based on F scale (frequency scale for the symptoms of GERD) and GSRS (gastrointestinal symptom rating scale)	—

Secondary

Measure	Time frame
Parameters of high resolution manometry (HRM) including DCI, IRP and LES pressure)	—

Countries

Japan

Contacts

Public ContactEikichi Ihara

Graduate School of Medical Sciences, Kyushu University Department of Medicine and Bioregulatory Science

eikichi@intmed3.med.kyushu-u.ac.jp81-92-642-5286

Outcome results